Zacks: Brokerages Expect Motus GI Holdings Inc (NASDAQ:MOTS) Will Announce Quarterly Sales of $80,000.00

Analysts forecast that Motus GI Holdings Inc (NASDAQ:MOTS) will post sales of $80,000.00 for the current quarter, Zacks reports. Two analysts have provided estimates for Motus GI’s earnings, with the highest sales estimate coming in at $100,000.00 and the lowest estimate coming in at $50,000.00. The firm is expected to report its next quarterly earnings report on Wednesday, November 13th.

According to Zacks, analysts expect that Motus GI will report full year sales of $710,000.00 for the current year, with estimates ranging from $410,000.00 to $1.00 million. For the next financial year, analysts forecast that the firm will post sales of $13.84 million, with estimates ranging from $11.07 million to $16.60 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Motus GI.

Motus GI (NASDAQ:MOTS) last announced its quarterly earnings results on Friday, August 9th. The company reported ($0.26) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.29) by $0.03.

MOTS has been the topic of a number of recent research reports. Dougherty & Co set a $7.00 target price on Motus GI and gave the company a “buy” rating in a research note on Thursday, September 26th. Zacks Investment Research lowered Motus GI from a “buy” rating to a “hold” rating in a research note on Thursday, August 15th. Finally, ValuEngine raised Motus GI from a “hold” rating to a “buy” rating in a research note on Tuesday, July 2nd.

Several institutional investors have recently modified their holdings of MOTS. Perceptive Advisors LLC lifted its stake in shares of Motus GI by 31.1% during the 2nd quarter. Perceptive Advisors LLC now owns 4,210,542 shares of the company’s stock worth $12,757,000 after purchasing an additional 1,000,000 shares during the period. Oracle Investment Management Inc. lifted its stake in shares of Motus GI by 35.7% during the 2nd quarter. Oracle Investment Management Inc. now owns 3,766,666 shares of the company’s stock worth $11,413,000 after purchasing an additional 991,666 shares during the period. Maven Securities LTD purchased a new position in shares of Motus GI during the 2nd quarter worth $1,037,000. Granite Point Capital Management L.P. purchased a new position in shares of Motus GI during the 2nd quarter worth $1,010,000. Finally, Vanguard Group Inc. purchased a new position in shares of Motus GI during the 2nd quarter worth $789,000. 44.96% of the stock is currently owned by institutional investors.

Shares of NASDAQ:MOTS traded up $0.07 during trading on Friday, hitting $1.78. 72,709 shares of the stock were exchanged, compared to its average volume of 95,537. Motus GI has a 12-month low of $1.67 and a 12-month high of $4.99. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.92 and a quick ratio of 3.89. The company has a fifty day moving average price of $2.37 and a two-hundred day moving average price of $3.15.

Motus GI Company Profile

Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Featured Story: Trading Options- What is a Strangle?

Get a free copy of the Zacks research report on Motus GI (MOTS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Motus GI (NASDAQ:MOTS)

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.